4 completed, 3 terminated, 2 active not recruiting, 2 enrolling by invitation. 6 Phase 1, 6 Phase 2, 2 Early Phase 1, 2 Not applicable, 2 Phase 3.
Follow Pyruvic Acid: new trials by email Literature Review of Pyruvic Acid trials Research Report on Pyruvic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone Abiraterone acetate, Prednisone, Hyperpolarized [1-13C] pyruvate (HP 13C) - High Risk Prostate Carcinoma, Prostate Cancer | Phase 2 | Active not recruiting | Ivan de Kouchkovsky, MD | 32 | 2024-12-09 | 2026-09-04 |
| Hyperpolarized MR Imaging With Carbon-13 Pyruvate in the Human Body Hyperpolarized 13C-pyruvate - Heart Failure, Cardiometabolic Syndrome | Phase 2 | Recruiting | National Heart Centre Singapore | 200 | 2024-10-17 | 2026-11-17 |
| Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study Dietary supplements - Nicotinamide and Pyruvate, Placebo - Primary Open Angle Glaucoma | Phase 2 / Phase 3 | Active not recruiting | Columbia University | 250 | 2023-03-14 | 2026-07-15 |
| Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma Alpelisib, Carboplatin, Hyperpolarized Carbon-13 (13C) Pyruvate - Solid Tumors, Adult, PIK3CA Mutation-Related Tumors | Phase 1 | Withdrawn | Pamela Munster | 2022-11-01 | 2022-12-27 | |
| A Study of [13C]Pyruvate as an Imaging Agent for Magnetic Resonance Imaging in Healthy Volunteers Hyperpolarized [13C] Pyruvate - Healthy Volunteers | Phase 1 | Enrolling by invitation | Memorial Sloan Kettering Cancer Center | 50 | 2021-09-01 | 2026-10-02 |
| Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) Vitamin B3, Pyruvate, Placebo - Visual Field Defect, Peripheral, Glaucoma, Open-Angle | Not applicable | Completed | Columbia University | 32 | 2019-04-15 | 2021-11-11 |
| Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate Hyperpolarized [1-13C] Pyruvate, Hyperpolarized [2-13C] Pyruvate - Traumatic Brain Injury | Early Phase 1 | Enrolling by invitation | University of Texas Southwestern Medical Center | 60 | 2018-06-01 | 2026-09-03 |
| Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer Pyruvate (13C), MRI - Prostate Cancer | Phase 1 | Terminated | Rahul Aggarwal | 8 | 2016-11-08 | 2020-07-24 |
| Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies Pyruvate (13C), MRI - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Rahul Aggarwal | 23 | 2016-10-20 | 2022-04-22 |
| MRI With C13 Pilot Study Prostate Cancer Pyruvate - Prostate Cancer | Early Phase 1 | Terminated | University of California, San Francisco | 5 | 2016-10-12 | 2018-10-23 |
| Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection Hyperpolarized (13) Pyruvate Injection, Gadolinium - Hypertension, Hypertrophy | Phase 1 | Recruiting | Sunnybrook Health Sciences Centre | 112 | 2016-04-01 | 2026-01-29 |
| Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts Pyruvic acid, Salicylic Acid - Plantar Wart | Phase 2 / Phase 3 | Unknown | Isfahan University of Medical Sciences | 60 | 2014-05-01 | 2014-05-30 |
| 13C-Pyruvate Breath Test 13C-Pyruvate 13C-lactate and dichloroacetate - Healthy | Phase 1 | Completed | University of Florida | 5 | 2013-03-01 | 2015-12-02 |
| Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation Pyruvate - Shock, Cardiogenic, Heart Failure | Phase 2 | Completed | Herzzentrum Goettingen | 8 | 2008-08-01 | 2010-12-09 |
| A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. Pyruvate, creatine, niacinamide, Placebo - Progressive Supranuclear Palsy | Not applicable | Completed | University of Louisville | 20 | 2004-04-01 | 2017-04-10 |
Prostatic Neoplasms (4) · Glaucoma, Open-Angle (2) · Heart Failure (2) · Brain Injuries, Traumatic (1) · Cardiovascular Diseases (1) · Glaucoma (1) · Hypertension (1) · Hypertrophy (1) · Metabolic Syndrome (1) · Neoplasm Metastasis (1) · Shock, Cardiogenic (1) · Supranuclear Palsy, Progressive (1) · Warts (1)
Columbia University (2) · Rahul Aggarwal (2) · Herzzentrum Goettingen (1) · Isfahan University of Medical Sciences (1) · Ivan de Kouchkovsky, MD (1) · Memorial Sloan Kettering Cancer Center (1) · National Heart Centre Singapore (1) · Pamela Munster (1) · Sunnybrook Health Sciences Centre (1) · University of California, San Francisco (1) · University of Florida (1) · University of Louisville (1) · University of Texas Southwestern Medical Center (1)
United States (10) · Canada (1) · Germany (1) · Iran (1) · Singapore (1)
Rahul Aggarwal, MD (3) · Aakriti G. Shukla, MD (1) · Charles Cunningham, PhD (1) · Fatima Assaf, M.D. (1) · Gerd Hasenfuss, Prof. Dr. (1) · Irene Litvan, MD (1) · Ivan de Kouchkovsky, MD (1) · Jeffrey M Liebmann, MD (1) · Pamela Munster, MD (1) · Peter W. Stacpoole, PhD, MD (1) · Vesselin Miloushev, MD (1)
PMID 21132310, PMID 27635086, PMID 34792559, PMID 38536128
R01CA166655 (1), R01CA183071 (1)